Insigma Technology (SHA:600797) said its joint-stock company completed listing on the Hong Kong Stock Exchange, according to a Shanghai Stock Exchange disclosure on Friday.
Hangzhou Jiuyuan Gene Engineering (HKG:2566) was listed on Nov. 28, offering 45.4 million shares for HK$12.42 apiece.
After the completion of the listing, the Chinese information technology services provider, through subsidiary Netnew Ventures, holds 24.5 million shares or 9.99% of Jiuyuan Gene Engineering. Netnew Ventures' lock-up period for Jiuyuan Gene shares is 12 months after the listing.
Insigma Technology's shares rose more than 2%, while Jiuyuan Gene Engineering's shares rose more than 4% in recent trade.
Comments